nitroglycerin has been researched along with bay 60-4552 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ackerstaff, J; Becker-Pelster, EM; Fey, P; Follmann, M; Geiss, V; Gerisch, M; Griebenow, N; Jautelat, R; Kern, A; Knorr, A; Kretschmer, A; Kroh, W; Lang, D; Li, V; Lustig, K; Mittendorf, J; Mondritzki, T; Redlich, G; Sandner, P; Schirok, H; Schlemmer, KH; Stasch, JP; Straub, A; Tinel, H; TrĂ¼bel, H; Wunder, F | 1 |
1 other study(ies) available for nitroglycerin and bay 60-4552
Article | Year |
---|---|
Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure.
Topics: Administration, Intravenous; Administration, Oral; Animals; Blood Pressure; Chemistry Techniques, Synthetic; Dogs; Heart Failure; Hepatocytes; Heterocyclic Compounds, 2-Ring; Humans; Male; NG-Nitroarginine Methyl Ester; Pyrimidines; Rats, Transgenic; Rats, Wistar; Soluble Guanylyl Cyclase; Structure-Activity Relationship | 2017 |